ES2520841T3 - Procedimiento para la producción de partículas - Google Patents

Procedimiento para la producción de partículas Download PDF

Info

Publication number
ES2520841T3
ES2520841T3 ES04712610.7T ES04712610T ES2520841T3 ES 2520841 T3 ES2520841 T3 ES 2520841T3 ES 04712610 T ES04712610 T ES 04712610T ES 2520841 T3 ES2520841 T3 ES 2520841T3
Authority
ES
Spain
Prior art keywords
substance
particles
production
procedure
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04712610.7T
Other languages
English (en)
Inventor
Robert Price
Joerg Sebastian Kaerger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Original Assignee
University of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32910470&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2520841(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0304037A external-priority patent/GB0304037D0/en
Priority claimed from GB0313129A external-priority patent/GB0313129D0/en
Application filed by University of Bath filed Critical University of Bath
Application granted granted Critical
Publication of ES2520841T3 publication Critical patent/ES2520841T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0027—Evaporation of components of the mixture to be separated by means of conveying fluid, e.g. spray-crystallisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0081—Use of vibrations, e.g. ultrasound
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento para la producción de partículas que comprende las etapas de i) formación de una solución de una sustancia deseada en un disolvente adecuado; ii) generación de un aerosol a partir de la solución de dicha sustancia; iii) recogida de las gotículas de aerosol en un recipiente que contiene un no disolvente de dicha sustancia; y iv) aplicación de ultrasonidos a las gotículas dispersadas en el no disolvente para efectuar la cristalización de dicha sustancia.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10

Claims (1)

  1. imagen1
ES04712610.7T 2003-02-21 2004-02-19 Procedimiento para la producción de partículas Expired - Lifetime ES2520841T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0304037A GB0304037D0 (en) 2003-02-21 2003-02-21 Process for the production of particles for use in pharmaceutical formulations
GB0304037 2003-02-21
GB0313129A GB0313129D0 (en) 2003-06-06 2003-06-06 Process for the production of particles
GB0313129 2003-06-06
PCT/GB2004/000654 WO2004073827A1 (en) 2003-02-21 2004-02-19 Process for the production of particles

Publications (1)

Publication Number Publication Date
ES2520841T3 true ES2520841T3 (es) 2014-11-11

Family

ID=32910470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04712610.7T Expired - Lifetime ES2520841T3 (es) 2003-02-21 2004-02-19 Procedimiento para la producción de partículas

Country Status (11)

Country Link
US (2) US20070065372A1 (es)
EP (1) EP1610878B1 (es)
JP (1) JP5154078B2 (es)
CA (1) CA2516733C (es)
DK (1) DK1610878T3 (es)
ES (1) ES2520841T3 (es)
NO (1) NO20053796L (es)
PL (1) PL224720B1 (es)
PT (1) PT1610878E (es)
SI (1) SI1610878T1 (es)
WO (1) WO2004073827A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032018A2 (en) * 2004-09-14 2006-03-23 Battelle Memorial Institute Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor
CA2617620A1 (en) 2005-08-04 2007-02-08 Vladimir Berentsveig Improved aerosol
GB0525852D0 (en) * 2005-12-20 2006-02-01 Accentus Plc Crystallisation apparatus and process
FR2897281B1 (fr) * 2006-02-14 2009-01-23 Saint Louis Inst Procede de fabrication par nanocristallisation de composes energetiques ou inertes
JP4597107B2 (ja) * 2006-03-02 2010-12-15 三井金属鉱業株式会社 砒素含有体からの砒素除去方法及び砒素除去装置
GB0610090D0 (en) * 2006-05-20 2006-06-28 Price Robert Particulate drug compositions and their uses
AU2008210270B8 (en) 2007-02-02 2012-04-26 Saban Ventures Pty Limited Membrane vapour concentrator
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
ES2310131B1 (es) * 2007-06-04 2009-12-04 INSTITUTO NACIONAL DE TECNICA AEROESPACIAL "ESTEBAN TERRADAS" Procedimiento de cristalizacion a partir de solucion.
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation
BRPI0915783A2 (pt) * 2008-07-18 2018-05-22 Prosonix Ltd processo para aumentar a cristalinidade de pelo menos um material sólido, partícula, composição farmacêutica ou agroquímica , e, inalador
WO2010097188A1 (en) 2009-02-25 2010-09-02 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a salt of carmoterol and a corticosteroid
GB0914240D0 (en) 2009-08-14 2009-09-30 Breath Ltd Steroid solvates
GB0914231D0 (en) * 2009-08-14 2009-09-30 Breath Ltd Dry powder inhaler formulations
GB0918431D0 (en) 2009-10-21 2009-12-09 Prosonix Ltd Process for improving crystallinity
MY162391A (en) 2010-04-01 2017-06-15 Chiesi Farm Spa Process for preparing carrier particles for dry powders for inhalation
EP2500072A1 (en) 2011-03-15 2012-09-19 LEK Pharmaceuticals d.d. A novel process of residual solvent removal
CN102166504B (zh) * 2011-03-22 2013-03-06 中国人民解放军第三0九医院 一种凝胶微球快速成型装置及方法
CN102350280B (zh) * 2011-06-23 2013-06-05 中国人民解放军第三0九医院 具有超声波振动装置的静电液滴发生装置及应用其制备载药凝胶微球的方法
US9643996B2 (en) 2011-11-04 2017-05-09 Battelle Memorial Institute Processes for producing protein microparticles
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
RU2663117C2 (ru) 2012-05-08 2018-08-01 Никокс Офтэлмикс, Инк. Препараты гидрофобных терапевтических средств, способы их получения и применения
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
CN104721052A (zh) * 2015-02-10 2015-06-24 武汉工程大学 一种纳米药物制备装置
US10583085B2 (en) 2017-05-17 2020-03-10 Chiesi Farmaceutici S.P.A. Carrier particles for dry powder formulations for inhalation
KR102092068B1 (ko) * 2018-03-26 2020-03-23 중앙대학교 산학협력단 약물 결정의 제조를 위한 비용매를 이용한 결정화 장치 및 이를 이용한 약물 결정의 제조 방법
BR112021001402A2 (pt) 2018-07-27 2021-04-27 Chiesi Farmaceutici S.P.A. novas partículas carreadoras para formulações de pó seco para inalação

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE99546T1 (de) * 1989-05-01 1994-01-15 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5874029A (en) * 1996-10-09 1999-02-23 The University Of Kansas Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
US6522582B1 (en) * 1999-03-05 2003-02-18 Xilinx, Inc. Non-volatile memory array using gate breakdown structures
JP3490015B2 (ja) * 1999-03-11 2004-01-26 関西ティー・エル・オー株式会社 化学的耐久性に優れた放射性微小球及びその製造方法
FR2797875B1 (fr) * 1999-08-26 2001-10-19 Hoechst Marion Roussel Inc Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
CH694686A5 (it) * 2000-03-04 2005-06-15 Eco2 Sa Prodotto di micronizzazione di sostanze farmaceutiche.
GB0008411D0 (en) * 2000-04-05 2000-05-24 Vectura Ltd Pharmaceutical preparations and their manufacture
AU2001254995A1 (en) * 2000-05-15 2001-11-26 Vectura Limited Method of manufacturing particles
PT1409101E (pt) 2001-05-05 2006-07-31 Accentus Plc Formacao de pequenos cristais
BR0309625A (pt) * 2002-04-29 2005-03-08 Bristol Myers Squibb Co Sistema de cristalização que utiliza atomização
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals

Also Published As

Publication number Publication date
US20170143632A1 (en) 2017-05-25
PT1610878E (pt) 2014-12-03
WO2004073827A1 (en) 2004-09-02
NO20053796D0 (no) 2005-08-11
JP5154078B2 (ja) 2013-02-27
PL224720B1 (pl) 2017-01-31
US20070065372A1 (en) 2007-03-22
PL378127A1 (pl) 2006-03-06
EP1610878A1 (en) 2006-01-04
CA2516733A1 (en) 2004-09-02
NO20053796L (no) 2005-11-03
SI1610878T1 (sl) 2015-02-27
EP1610878B1 (en) 2014-09-03
JP2006519780A (ja) 2006-08-31
DK1610878T3 (da) 2014-12-01
CA2516733C (en) 2011-09-27

Similar Documents

Publication Publication Date Title
ES2520841T3 (es) Procedimiento para la producción de partículas
ES2651675T3 (es) Producción de grafeno a partir de alcóxido de metal
ES2634539T3 (es) Dispositivo para terapia por inhalación
ES2373436T5 (es) Método y dispositivo para preparar una bebida a partir de cápsulas conteniendo una substancia
ES2629089T3 (es) Utilización de 2,6-Di-terc-butil-p-cresol para el aumento de la estabilidad en almacenamiento de biodiésel
RU2008114306A (ru) Способ получения лекарственной композиции, основанный на увеличении сродства поверхностей кристаллических микрочастиц к активным агентам
JP2010508368A5 (es)
AR038685A1 (es) Metodo y aparato para evaporar liquidos de multiples componentes
CO5670354A2 (es) Proceso para la elaboracion de aripiprazol esteril de tamaño particula promedio deseado
ES2554527T3 (es) Proceso para rellenar partículas poliméricas con un fármaco
MXPA05007154A (es) Atomizador prepeliculizacion.
ES2422433T3 (es) Procedimiento para la preparación de partículas esféricas a partir de una sustancia farmacéutica
EP2357044A3 (en) Energy storage device product and method for making a energy storage device electrode
EA200400878A1 (ru) Новые эфиры флуоренкарбоновых кислот, способ их получения, а также их применение в качестве лекарственных средств
ECSP056071A (es) Nueva difenilazetidinona con características fisiológicas mejoradas, correspondiente método de producción, medicamentos que contienen dicho compuesto y su uso
ATE556788T1 (de) Herstellung pharmazeutischer wirkstoffpartikel unter verwendung fokussierter akustischer energie
ES2574002T3 (es) Electrocatalizador de rodio y método de preparación
EP2338608A3 (en) Ultrasonic atomization method and apparatus
AR043343A1 (es) Procedimiento para modificar formacion de cristal de farmaco
Gabarayeva et al. Sporoderm development in Acer tataricum (Aceraceae): an interpretation
GB0413110D0 (en) Cooling apparatus
Gabarayeva et al. Sporoderm and tapetum development in Eupomatia laurina (Eupomatiaceae). An interpretation
WO2006035425A3 (en) Spray method for producing semiconductor nanoparticles
McDougall et al. Microinjection and 4D fluorescence imaging in the eggs and embryos of the ascidian Phallusia mammillata
AR048756A1 (es) Procedimiento para formar atorvastatina amorfa